69938-07-4 Usage
General Description
Alpha-monofluoromethyldopa is a chemical compound that is similar to the neurotransmitter dopamine and is used as a precursor to fluorine-labeled positron emission tomography (PET) radiopharmaceuticals. It is often used in medical research to study the neurobiology of neuropsychiatric disorders such as depression and schizophrenia. Alpha-monofluoromethyldopa is also being investigated for potential use in the diagnosis and treatment of various neurological and psychiatric conditions. As a fluorinated compound, it has unique properties that make it useful for labeling and tracking dopamine receptor activity in the brain, and it has shown promise in enhancing the understanding of neurochemical pathways involved in mood and cognitive function.
Check Digit Verification of cas no
The CAS Registry Mumber 69938-07-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,9,3 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 69938-07:
(7*6)+(6*9)+(5*9)+(4*3)+(3*8)+(2*0)+(1*7)=184
184 % 10 = 4
So 69938-07-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12FNO4/c11-5-10(12,9(15)16)4-6-1-2-7(13)8(14)3-6/h1-3,13-14H,4-5,12H2,(H,15,16)/t10-/m1/s1
69938-07-4Relevant articles and documents
Fluorinated amino acids
-
, (2008/06/13)
Novel substituted α-fluoromethyl-α-amino alkanoic acids and esters thereof are disclosed. The novel compounds have biological activity including decarboxylase inhibition.
Method of depleting endogenous monoamines
-
, (2008/06/13)
2-Amino-2-fluoromethyl-3-(substituted)phenyl propionic acids and derivatives thereof are coadministered with dopamine for the treatment of schizophrenia, mania, tardive dyskinesia, anxiety, or depression.
